Helen Dauben
Impact in
- Physiology top 5%
- Calcium signaling and nucleotide metabolism
- Oncology top 10%
- PARP inhibition in cancer therapy
Papers in
-
- RNA and protein synthesis mechanisms 1
- CRISPR and Genetic Engineering 1
- Oncology 5
- PARP inhibition in cancer therapy 5
- Co-authors
- Ivan Matić (5 shared papers)Orsolya Leidecker (2 shared papers)Ivan Ahel (2 shared papers)Evgeniia Prokhorova (1 shared paper)Luca Palazzo (1 shared paper)Thomas Colby (2 shared papers)Juán José Bonfiglio (2 shared papers)Pablo San Segundo‐Acosta (1 shared paper)
- Journals
- Trends in Biochemical Sciences (2 papers)eLife (1 paper)Cell (1 paper)Molecular Cell (1 paper)Nature Communications (1 paper)
- Partner nations
- GermanyUnited KingdomHungary
In The Last Decade
Helen Dauben
5 papers receiving 361 citations
Peers
Comparison fields: 5 of 46
- Physiology 66
- Oncology 274
- Immunology 96
- Molecular Biology 219
- Geriatrics and Gerontology 10
Countries citing papers authored by Helen Dauben
This map shows the geographic impact of Helen Dauben's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen Dauben with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen Dauben more than expected).
Fields of papers citing papers by Helen Dauben
This network shows the impact of papers produced by Helen Dauben. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen Dauben. The network helps show where Helen Dauben may publish in the future.
Co-authors
The 25 scholars most cited alongside Helen Dauben, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 192 | |
| 2 | 2020 | 72 | |
| 3 | 2019 | 55 | |
| 4 | 2023 | 44 | |
| 5 | 2023 | 2 | |
| 6 | 2023 | 0 | |
| 7 | 2023 | 0 |
About Helen Dauben
Helen Dauben is a scholar working on Molecular Biology, Oncology, Immunology, Plant Science and Physiology, having authored 7 papers that have together received 365 indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (5 papers), Toxin Mechanisms and Immunotoxins (5 papers), Plant Molecular Biology Research (1 paper), Plant-Microbe Interactions and Immunity (1 paper), Mycotoxins in Agriculture and Food (1 paper), RNA and protein synthesis mechanisms (1 paper), CRISPR and Genetic Engineering (1 paper) and Calcium signaling and nucleotide metabolism (1 paper). The work is most often cited by research in Physiology (66 citations), Oncology (274 citations), Immunology (96 citations), Molecular Biology (219 citations) and Geriatrics and Gerontology (10 citations). Helen Dauben has collaborated with scholars based in Germany, United Kingdom and Hungary. Frequent co-authors include Ivan Matić, Orsolya Leidecker, Ivan Ahel, Evgeniia Prokhorova, Luca Palazzo, Thomas Colby, Juán José Bonfiglio, Pablo San Segundo‐Acosta, Kathryn Perez and Pitter F. Huesgen. Their work appears in journals such as Trends in Biochemical Sciences, eLife, Cell, Molecular Cell and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.